标普生物科技ETF-SPDR

169.04
开盘价
166.18
市值
11.41B+
最高价
169.89
最低价
165.79
收盘价
169.10
成交量
9.90M+
市盈率
0.00
股息率
0.00%

标普生物科技ETF-SPDR简介

SPDR系列信托-SPDR S&P Biotech ETF是由道富环球顾问公司推出的交易所交易基金。该基金由SSGA Funds Management,Inc.管理。它投资于美国的公开股票市场。它投资于医疗保健、制药、生物技术和生命科学领域的公司股票。该基金投资于不同市值公司的成长型和价值型股票。它寻求通过使用具有代表性的抽样技术来跟踪标准普尔生物技术精选行业指数的表现。SPDR系列信托-SPDR标准普尔生物技术ETF成立于2006年1月31日,注册地为美国。

如何购买 标普生物科技ETF-SPDR (XBI)

登录
1分钟开户

1分钟开户

仅需1分钟即可完成账户申请和验证。整个过程完全自助,支持 RockFlow App 和网页端操作。

充值资金

充值资金

账户验证完成后,您可以使用首选的支付方式向账户充值。

购买 XBI

购买 XBI

通过 RockFlow App 或网页端搜索 XBI,输入您想要投资的金额,然后点击确认即可完成交易。

logo

社交媒体

Download

google playapp store

© Rockalpha Limited. All Rights Reserved.

Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider. Rockalpha Limited is not licensed by a New Zealand regulator to provide the client money or property services, and Rockalpha Limited’s registration on the New Zealand register of financial service providers or membership of the Insurance & Financial Services Ombudsman Scheme does not mean that Rockalpha Limited is subject to active regulation or oversight by a New Zealand regulator.Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider.